ReviewFrontiers in bioengineering and biotechnology2026
Quercetin in skin burn healing: mechanisms, advanced delivery systems, and translational perspectives.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burn injuries remain a significant global health challenge, often leading to prolonged healing, infection, and scarring. Addressing these complications requires innovative therapeutic strategies that can accelerate tissue repair and minimize adverse outcomes. Quercetin, a widely distributed plant-derived flavonoid, has emerged as a promising multi-functional agent in burn wound management. This review presents a comprehensive overview of quercetin's therapeutic potential, emphasizing its pharmacological versatility and the need for advanced topical delivery systems such as nanostructured lipid carriers and hydrogels to overcome its limited bioavailability. Quercetin's efficacy is rooted in its multi-targeted mechanisms of action. It exhibits potent antioxidant activity by directly scavenging reactive oxygen and nitrogen species and activating the Nrf2-ARE signaling pathway, thereby enhancing endogenous antioxidant defenses. Its anti-inflammatory effects are mediated through the inhibition of NF-κB and MAPK pathways, leading to the suppression of key pro-inflammatory cytokines. Quercetin also promotes angiogenesis via upregulation of vascular endothelial growth factor (VEGF), supports fibroblast proliferation and extracellular matrix remodeling, and facilitates re-epithelialization. This review consolidates dispersed experimental findings into a unified mechanistic and translational framework, highlighting why quercetin is uniquely positioned among phytochemicals for burn therapy. By integrating pharmacodynamics, formulation science, and clinical feasibility, the article clarifies current evidence gaps and outlines practical directions for therapeutic development. Such synthesis is timely because research on flavonoid-based wound therapeutics is expanding rapidly but remains fragmented across disciplines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.